HKU Scholars Hub: Browsing DSpace

Browsing by Author Kreter, B

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 3 to 7 of 7 < previous

	Title	Author(s)	Issue Date	Views
	Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901 Proceeding/Conference:Hepatology	Liaw, YF Chang, TT Wu, SS Schiff, ER Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2008	160
	Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Journal:Hepatology	Chang, TT Liaw, YF Wu, SS Schiff, E Han, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, Z Chi, YC Zhang, H Hindes, R Iloeje, U Beebe, S Kreter, B	2010	180
	Long-term follow-up of entecavir treated protocol-defined non responders in rollover study ETV-901 Proceeding/Conference:Hepatology	Sherman, M Rizzetto, M Lai, CL Liaw, YF Gadano, A Jacobson, IM Schiff, ER Yang, J Colonno, R Kreter, B Hindes, R	2007	69
	Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs Proceeding/Conference:Gastroenterology	Liaw, YF Chang, TT Wu, SS Schiff, ER Kan, KH Lai, CL Safadi, R Lee, SS Halota, W Goodman, ZD Zhang, H Iloeje, UH Beebe, S Kreter, B Ishikawa, H Katano, Y Takaguchi, K Omata, M	2009	14
	Presence of Biopsy-Proven Histologic Damage (Necroinflammation and Fibrosis) is Common Even When ALT is Less Than 2 x ULN in Patients with Chronic Hepatitis B (CHB) in Entecavir Studies ETV-022 (HBeAg+) and ETV-027 (HBeAg-) Proceeding/Conference:Digestive Disease Week	Terrault, N Kim, WR Lim, SG Papatheodoridis, G Alberti, A Yuen, RMF Goodman, ZD Vaughan, J Wilber, R Kreter, B	2007	103

Showing results 3 to 7 of 7 < previous